NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000002058

Registered date:01/07/2009

Effect of lanthanum carbonate on medical cost and laboratory values in hemodialysis patients with hyperphosphatemia

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedHyperphosphatemia
Date of first enrollment2009/05/01
Target sample size150
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary Outcome1, Change in phosphate, calcium, and parathyroid hormone before and after lanthanum carbonate treatment. 2, Change in the dose of calcium containing phosphate binder, sevelamer, vitamin D analogues, and cinacalcet. 3, Medical cost of lanthanum carbonate
Secondary OutcomeSide effect of lanthanum carbonate

Key inclusion & exclusion criteria

Age minimum18years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteria1, The patients who don't agree with this study 2, The patients who are judged inappropriate for the study by the physician

Related Information

Contact

public contact
Name Masafumi Fukagawa
Address 7-5-2, Kusunoki-cho, Chuo-ku, Kobe 650-0017 Japan
Telephone 078-382-6500
E-mail fukagawa@med.kobe-u.ac.jp
Affiliation Kobe University Graduate School of Medicine Division of Nephrology and Kidney Center
scientific contact
Name Masafumi Fukagawa
Address 7-5-2, Kusunoki-cho, Chuo-ku, Kobe 650-0017 Japan
Telephone
E-mail
Affiliation Kobe University Graduate School of Medicine Division of Nephrology and Kidney Center